Hallett David — SEC insider filings

SEC reporting owner CIK 2006495. 5 insider filings on record with FilingPulse; latest filed 2026-11-18.

Transaction summary — filings shown

Covers all 5 filings on record, filed 2026-02-10 to 2026-11-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
RECURSION PHARMACEUTICALS, INC. (RXRX)Chief Scientific Officer5——7

Insider filings — Hallett David

FiledFormIssuerReported transactionsSource
2026-11-184RECURSION PHARMACEUTICALS, INC. (RXRX)Tax withholding (F): 26,657 @ $3.19EDGAR
2026-08-184RECURSION PHARMACEUTICALS, INC. (RXRX)Tax withholding (F): 26,657 @ $3.16EDGAR
2026-05-194RECURSION PHARMACEUTICALS, INC. (RXRX)Tax withholding (F): 26,657 @ $3.04EDGAR
2026-02-194RECURSION PHARMACEUTICALS, INC. (RXRX)Tax withholding (F): 11,908 @ $3.49EDGAR
2026-02-104RECURSION PHARMACEUTICALS, INC. (RXRX)Grant/award (A): 502,064 @ $0 · Grant/award (A): 24,254 @ $0 · Tax withholding (F): 11,400 @ $3.98EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-09-28 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2006495 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs